Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
Clinical trial COUGAR, sponsored by University Hospital, Brest, will evaluate ultrasonic comparisons of salivary glands across autoimmune di…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 2]
A Phase 2 dose-range study in adults with rheumatoid arthritis who have an inadequate response to methotrexate has completed, evaluating the…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Diet and Rheumatoid Arthritis Risk in the United Kingdom Women's Cohort
The document reports the completion of a UK Women's Cohort clinical trial investigating whether dietary factors influence the risk of develo…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Dietary Factors and Rheumatoid Arthritis Risk in the UK Biobank
This clinical trial update from University of Leeds investigates whether dietary factors influence the risk of developing rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate [Phase 2]
Update on a Phase 2 trial evaluating ASP5094 in rheumatoid arthritis patients on methotrexate; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of ASP5094 after multiple intravenous doses in rheumatoid arthritis pati…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) [Phase 4]
Phase 4 clinical trial comparing biologics plus methotrexate versus biologics plus tacrolimus in rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis
Pfizer reports completion of a special investigation evaluating tofacitinib (Xeljanz) for rheumatoid arthritis, with results posted on 2024-…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Incorporating PRO Data Into RA Clinical Encounters Using Health IT [NA]
A completed clinical trial evaluating incorporating patient-reported outcome (PRO) data into rheumatoid arthritis clinic encounters using he…
-
EMA approval · 2024-10-24EMA Authorised: Jylamvo (methotrexate) — Oresund Pharma ApS
The European Medicines Agency authorised Jylamvo, a methotrexate product from Oresund Pharma ApS, for indications including psoriatic arthri…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Scintigraphy for Prediction In Rheumatoid Intentional Therapy Tapering
A clinical trial evaluating whether scintigraphy can predict which rheumatoid arthritis patients may safely taper their therapy.
-
FDA approval · 2024-10-23FDA Approved: JYLAMVO — Supplemental Application (SHORLA ONCOLOGY INC.)
The FDA approved a supplemental application for JYLAMVO (methotrexate) filed by SHORLA ONCOLOGY INC.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]
A Phase 1 pharmacokinetic study evaluating ASP1707 in combination with Methotrexate in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate [Phase 2]
A Phase 2 study evaluated ASP1707 in postmenopausal women with rheumatoid arthritis on methotrexate to assess efficacy and safety. The trial…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects [Phase 2]
Phase 2 study evaluating the efficacy and safety of ASP015K in adults with moderate to severe rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study [Phase 2]
This clinical trial update reports the long-term safety and efficacy of ASP015K in subjects previously enrolled in a Phase 2 rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 drug interaction study evaluating the pharmacokinetics of ASP015K with methotrexate in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) [Phase 3]
A Phase 3 trial evaluating ASP015K for rheumatoid arthritis in MTX-inadequate responders has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis
A completed observational study evaluating how physicians decide on treatment for patients with rheumatoid arthritis treated with tofacitini…
-
CLINICAL_TRIALS other · 2024-10-18Clinical Trial Update: MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial named MethMax is evaluating maximization of methotrexate therapy in patients with active rheumatoid arthritis. The st…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate [Phase 4]
Phase 4 clinical trial update exploring whether empagliflozin may provide protective effects and potential efficacy in rheumatoid arthritis …
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients [Phase 2]
An ongoing Phase 2 clinical trial evaluating nicotinamide for improving clinical outcomes in patients with rheumatoid arthritis, currently r…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 study update reporting safety, tolerability, and pharmacokinetics of oral doses of TCK-276 in patients with rheumatoid arthritis; re…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Phase 3]
Phase 3 trial update reporting results from a head-to-head comparison of abatacept versus adalimumab, each added to background methotrexate,…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Impact of Air Pollution on the Course of Inflammatory Rheumatism [NA]
A clinical trial investigating the impact of air pollution on the course of inflammatory rheumatic diseases, including rheumatoid arthritis,…